Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis

BACKGROUND: HIV co-infection exacerbates hepatitis C disease, increasing the risk of cirrhosis and hepatitis C-related mortality. Combination antiretroviral therapy (cART) is the current standard treatment for co-infected individuals, but the impact of cART and antiretroviral (ARV) monotherapy on li...

Descripción completa

Detalles Bibliográficos
Autores principales: Llewellyn, Alexis, Simmonds, Mark, Irving, Will L, Brunton, Ginny, Sowden, Amanda J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918754/
https://www.ncbi.nlm.nih.gov/pubmed/30288314
http://dx.doi.org/10.1186/s41124-016-0015-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918754/
https://www.ncbi.nlm.nih.gov/pubmed/30288314
http://dx.doi.org/10.1186/s41124-016-0015-7

Ejemplares similares